BOLALARDA OBSTRUKTIV BRONXITNING KECHISHI VA NATIJASIGA ICHAK MIKROFLORASINING TA'SIRI
##article.subject##:
обструктивный бронхит, микрофлора кишечника, дети##article.abstract##
Tibbiy amaliyot an'anaviy ravishda nafas olish yo'llari kasalliklarining keng tarqalganligi sababli ularga alohida e'tibor beradi va ularning oldini olish va davolashni ustuvor vazifa qilib qo'yadi. Zamonaviy tadqiqotlar ichak mikrobiotasi va nafas olish tizimi o'rtasidagi bog'liqlikni tasdiqlaydi; nafas olish yo'llari kasalliklarining rivojlanishi va mexanizmlarida foydali bakteriyalarning roli faol o'rganilmoqda. Bundan tashqari, oshqozon-ichak mikroflorasi nafaqat mahalliy immunitetni himoya qiladi, balki bolalarda immunitetni rivojlantirish uchun ham juda muhimdir. Bizning maqsadimiz tez-tez kasal bo'ladigan bolalarda obstruktiv bronxitning kechishi va natijasiga ichak mikroflorasining ta'sirini o'rganish edi. Ushbu maqsadga erishish uchun biz Respublika shoshilinch tibbiy yordam ilmiy markazining Samarqand filialining pediatriya bo'limlarida, Samarqand viloyat bolalar ko'p tarmoqli tibbiyot markazida va 3-sonli oilaviy klinikalarda tadqiqotlar o'tkazdik. Tadqiqot guruhlariga 1 yoshdan 10 yoshgacha bo'lgan 52 nafar jamoat joyida obstruktiv bronxit bilan og'rigan bemor kiritilgan. 1-guruhga probiotik bilan kombinatsiyalangan terapiya olgan 26 nafar jamoat joyida obstruktiv bronxit bilan og'rigan bemor kiritilgan. 2-guruhga an'anaviy davolanish olgan 26 nafar jamoat joyida obstruktiv bronxit bilan og'rigan bemor kiritilgan.
Библиографические ссылки
Авдеев С.Н. Интенсивная терапия в пульмонологии. М., 2015. Т. 1. 304 с.
Шавази, Н., & Ибрагимова, М. (2025). Bolalarda xlamidial pnevmoniyani tashxis va davolash usullarini takоmillashtirish. Международный журнал научной педиатрии, 4(1), 801-803.
Ibragimova Marina Fedorovna. (2022). The influence of risk factors on the development of atypical pneumonia in young children. asian Journal of Pharmaceutical and Biological Research 2231-2218, Volume 11(Issue 2), 49–51.
Odamaki T., Kato K., Sugahara H., et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016; 16: 90-8.
Fedorovna, I. M., & Kizi, S. Z. S. (2023). STATE OF HUMORAL IMMUNITY IN PATIENTS WITH ATYPICAL PNEUMONIA IN FREQUENTLY ILL CHILDREN. Research Focus, 2(10), 125-128.
Moré M.I., Swidsinski A. Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – A review. Clinical and Experimental Gastroenterology. 2015; 8: 237–255.
Омонова, Г. З., & Ибрагимова, М. Ф. (2025). ОСОБЕННОСТИ ТЕЧЕНИЯ ПНЕВМОНИИ У ГРУДНЫХ ДЕТЕЙ С ДИСПЕПТИЧЕСКИМ СИНДРОМОМ. Вестник Ассоциации Пульмонологов Центральной Азии, 12(7), 72-75.
McFarland L.V. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World Journal of Gastroenterology. 2010; 16 (18): 2202–2222.
Joly F. et al. Saccharomyces boulardii CNCM I-745. In: Marteau P., Dore J., eds. Gut Microbiota: A Full-Fledged Organ. Paris: John Libbey Eurotext; 2017: 305–350.
Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis, 2010 Apr, 16(4): 604-9. doi: 10.3201/ eid1604.090680.
Powell N, Jung SE, Krishnan B. Clostridium difficile infection and inflammatory bowel disease: a marker for disease extent? Gut, 2008, 57: 1183-1184.
